Open AccessDevelopment of a Conceptual Model of Adherence to Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation
Author(s) -
T. Michelle Brown,
Kimberly Siu,
David Walker,
Manel Pladevall,
Stephen Sander,
Margaret Mordin
Publication year - 2012
Publication title -
journal of managed care pharmacy
Language(s) - English
Resource type - Journals
eISSN - 1944-706X
pISSN - 1083-4087
DOI - 10.18553/jmcp.2012.18.5.351
Subject(s) - medicine , atrial fibrillation , focus group , warfarin , stroke (engine) , medication adherence , qualitative research , physical therapy , medline , family medicine , intensive care medicine , business , law , political science , mechanical engineering , sociology , social science , marketing , engineering
Oral anticoagulant (OA) medication is the recommended therapy for reducing the risk of thromboembolic complications in patients with atrial fibrillation (AF), and warfarin is the medication most frequently used. However, nonadherence associated with OA medications may lead to considerable health risks. A conceptual model of OA medication adherence in patients with AF could clarify factors affecting adherence, thereby assisting in the development and structuring of adherence-promotion programs. To our knowledge, such a model, driven by information obtained directly from patients, has never been developed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom